The nature of secondary hyperparathyroidism (SHPT) is a compensatory response of the parathyroid glands to chronic pathological stimuli, with core triggers including chronic kidney disease (CKD)-related phosphorus retention, active vitamin D deficiency and fibroblast growth factor 23 (FGF23). This evidence concerns the gene FGF23 and vitamin D deficiency.